Case Name: UNITED STATES of America, Plaintiff-Appellee, v. Rocky WALLACE, Defendant-Appellant
Court: United States Court of Appeals for the Fifth Circuit
Jurisdiction: United States
Decision Date: 2017-09-14
Citations: 697 F. App'x 375
Docket Number: No. 16-11784 Summary Calendar
Parties: UNITED STATES of America, Plaintiff-Appellee, v. Rocky WALLACE, Defendant-Appellant.
Judges: Before JOLLY, OWEN, and HAYNES, Circuit Judges.
Reporter: West's Federal Appendix
Volume: 697
Pages: 375–376

Head Matter:
UNITED STATES of America, Plaintiff-Appellee, v. Rocky WALLACE, Defendant-Appellant.
No. 16-11784 Summary Calendar
United States Court of Appeals, Fifth Circuit.
Filed September 14, 2017
Brian W. McKay, Esq., Assistant U.S. Attorney, James Wesley Hendrix, Assis tant U.S. Attorney, U.S. Attorney’s Office, Northern District of Texas, Dallas, TX, for Plaintiff-Appellee
Leandro Delgado, Assistant Federal Public Defender, Federal Public Defender’s Office, Northern District of Texas, Fort Worth, TX, for Defendant-Appellant
Before JOLLY, OWEN, and HAYNES, Circuit Judges.

Opinion:
PER CURIAM:
Rocky Wallace appeals the district court's judgment revoking his term of supervised release and sentencing him to 18 months of imprisonment and 18 months of supervised release. He argues that the treatment exception set forth in 18 U.S.C. § 3583(d) applies in any case where a su-pervisee fails a drug test, regardless of any other violations committed, and that the district court failed to consider the treatment exception as required by § 3583(d). He also argues that the sentence imposed is substantively unreasonable.
This court generally reviews the district court's decision to revoke a term of supervised release for an abuse of discretion. United States v. McCormick, 54 F.3d 214, 219 (5th Cir. 1995). This court reviews a revocation sentence under the plainly unreasonable standard in two steps, examining first for procedural error and then for obvious substantive unreasonableness. United States v. Warren, 720 F.3d 321, 326 (5th Cir. 2013). However, issues of statutory interpretation are reviewed de novo. See United States v. Clayton, 613 F.3d 592, 595 (5th Cir. 2010).
We need not clarify whether the district court is required to consider § 3583(d) in cases, like this one, where the revocation of supervised release is based on more than failed drug tests. See United States v. Brooker, 858 F.3d 983, 986 (5th Cir. 2017). Although the district court did not explicitly address the drug treatment exception argument or its reasons for rejecting same prior to revocation, the district court did implicitly consider and explicitly reject that argument. See id. at 986-87. As such, the record does not indicate that the district court failed to consider the drug treatment exception of § 3583(d). See id.
Wallace has failed to show that the district court committed any clear error in imposing his sentence or that the sentence is unreasonable. See United States v. Miller, 634 F.3d 841, 843 (5th Cir. 2011); United States v. Whitelaw, 580 F.3d 256, 260 (5th Cir. 2009); see, e.g., United States v. Kippers, 685 F.3d 491, 500-01 (5th Cir. 2012).
Accordingly, the district court's judgment is AFFIRMED.
Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.